1 Bisphosphonate Drug Market Overview 1.1 Product Overview and Scope of Bisphosphonate Drug 1.2 Bisphosphonate Drug Segment by Type 1.2.1 Global Bisphosphonate Drug Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Alendronate 1.2.3 Risedronate 1.2.4 Zoledronic Acid 1.2.5 Other Bisphosphonate Drug 1.3 Bisphosphonate Drug Segment by Application 1.3.1 Global Bisphosphonate Drug Sales Comparison by Application: (2021-2027) 1.3.2 Postmenopausal Osteoporosis 1.3.3 Men with Osteoporosis 1.3.4 Paget’s Disease 1.3.5 Bone Loss Caused by Cancer Treatment 1.3.6 Osteoporosis Imperfecta in Children 1.4 Global Bisphosphonate Drug Market Size Estimates and Forecasts 1.4.1 Global Bisphosphonate Drug Revenue 2016-2027 1.4.2 Global Bisphosphonate Drug Sales 2016-2027 1.4.3 Bisphosphonate Drug Market Size by Region: 2016 Versus 2021 Versus 2027 2 Bisphosphonate Drug Market Competition by Manufacturers 2.1 Global Bisphosphonate Drug Sales Market Share by Manufacturers (2016-2021) 2.2 Global Bisphosphonate Drug Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Bisphosphonate Drug Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Bisphosphonate Drug Manufacturing Sites, Area Served, Product Type 2.5 Bisphosphonate Drug Market Competitive Situation and Trends 2.5.1 Bisphosphonate Drug Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Bisphosphonate Drug Players Market Share by Revenue 2.5.3 Global Bisphosphonate Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Bisphosphonate Drug Retrospective Market Scenario by Region 3.1 Global Bisphosphonate Drug Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Bisphosphonate Drug Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Bisphosphonate Drug Market Facts & Figures by Country 3.3.1 North America Bisphosphonate Drug Sales by Country 3.3.2 North America Bisphosphonate Drug Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Bisphosphonate Drug Market Facts & Figures by Country 3.4.1 Europe Bisphosphonate Drug Sales by Country 3.4.2 Europe Bisphosphonate Drug Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Bisphosphonate Drug Market Facts & Figures by Region 3.5.1 Asia Pacific Bisphosphonate Drug Sales by Region 3.5.2 Asia Pacific Bisphosphonate Drug Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Bisphosphonate Drug Market Facts & Figures by Country 3.6.1 Latin America Bisphosphonate Drug Sales by Country 3.6.2 Latin America Bisphosphonate Drug Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Bisphosphonate Drug Market Facts & Figures by Country 3.7.1 Middle East and Africa Bisphosphonate Drug Sales by Country 3.7.2 Middle East and Africa Bisphosphonate Drug Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Bisphosphonate Drug Historic Market Analysis by Type 4.1 Global Bisphosphonate Drug Sales Market Share by Type (2016-2021) 4.2 Global Bisphosphonate Drug Revenue Market Share by Type (2016-2021) 4.3 Global Bisphosphonate Drug Price by Type (2016-2021) 5 Global Bisphosphonate Drug Historic Market Analysis by Application 5.1 Global Bisphosphonate Drug Sales Market Share by Application (2016-2021) 5.2 Global Bisphosphonate Drug Revenue Market Share by Application (2016-2021) 5.3 Global Bisphosphonate Drug Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Merck 6.1.1 Merck Corporation Information 6.1.2 Merck Description and Business Overview 6.1.3 Merck Bisphosphonate Drug Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Merck Bisphosphonate Drug Product Portfolio 6.1.5 Merck Recent Developments/Updates 6.2 Teva 6.2.1 Teva Corporation Information 6.2.2 Teva Description and Business Overview 6.2.3 Teva Bisphosphonate Drug Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Teva Bisphosphonate Drug Product Portfolio 6.2.5 Teva Recent Developments/Updates 6.3 Mylan 6.3.1 Mylan Corporation Information 6.3.2 Mylan Description and Business Overview 6.3.3 Mylan Bisphosphonate Drug Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Mylan Bisphosphonate Drug Product Portfolio 6.3.5 Mylan Recent Developments/Updates 6.4 Apotex Corp 6.4.1 Apotex Corp Corporation Information 6.4.2 Apotex Corp Description and Business Overview 6.4.3 Apotex Corp Bisphosphonate Drug Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Apotex Corp Bisphosphonate Drug Product Portfolio 6.4.5 Apotex Corp Recent Developments/Updates 6.5 Cobalt Pharmaceuticals 6.5.1 Cobalt Pharmaceuticals Corporation Information 6.5.2 Cobalt Pharmaceuticals Description and Business Overview 6.5.3 Cobalt Pharmaceuticals Bisphosphonate Drug Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Cobalt Pharmaceuticals Bisphosphonate Drug Product Portfolio 6.5.5 Cobalt Pharmaceuticals Recent Developments/Updates 6.6 Genentech 6.6.1 Genentech Corporation Information 6.6.2 Genentech Description and Business Overview 6.6.3 Genentech Bisphosphonate Drug Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Genentech Bisphosphonate Drug Product Portfolio 6.6.5 Genentech Recent Developments/Updates 6.7 Novartis Pharmaceuticals 6.6.1 Novartis Pharmaceuticals Corporation Information 6.6.2 Novartis Pharmaceuticals Description and Business Overview 6.6.3 Novartis Pharmaceuticals Bisphosphonate Drug Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Novartis Pharmaceuticals Bisphosphonate Drug Product Portfolio 6.7.5 Novartis Pharmaceuticals Recent Developments/Updates 6.8 Sanofi-Aventis 6.8.1 Sanofi-Aventis Corporation Information 6.8.2 Sanofi-Aventis Description and Business Overview 6.8.3 Sanofi-Aventis Bisphosphonate Drug Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Sanofi-Aventis Bisphosphonate Drug Product Portfolio 6.8.5 Sanofi-Aventis Recent Developments/Updates 7 Bisphosphonate Drug Manufacturing Cost Analysis 7.1 Bisphosphonate Drug Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Bisphosphonate Drug 7.4 Bisphosphonate Drug Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Bisphosphonate Drug Distributors List 8.3 Bisphosphonate Drug Customers 9 Bisphosphonate Drug Market Dynamics 9.1 Bisphosphonate Drug Industry Trends 9.2 Bisphosphonate Drug Growth Drivers 9.3 Bisphosphonate Drug Market Challenges 9.4 Bisphosphonate Drug Market Restraints 10 Global Market Forecast 10.1 Bisphosphonate Drug Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Bisphosphonate Drug by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Bisphosphonate Drug by Type (2022-2027) 10.2 Bisphosphonate Drug Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Bisphosphonate Drug by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Bisphosphonate Drug by Application (2022-2027) 10.3 Bisphosphonate Drug Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Bisphosphonate Drug by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Bisphosphonate Drug by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Bisphosphonate Drug Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Bisphosphonate Drug Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Bisphosphonate Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Bisphosphonate Drug Covered in This Study Table 5. Global Bisphosphonate Drug Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Bisphosphonate Drug Sales Market Share by Manufacturers (2016-2021) Table 7. Global Bisphosphonate Drug Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Bisphosphonate Drug Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Bisphosphonate Drug Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Bisphosphonate Drug Manufacturing Sites and Area Served Table 11. Manufacturers Bisphosphonate Drug Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Bisphosphonate Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bisphosphonate Drug as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Bisphosphonate Drug Sales by Region (2016-2021) & (K Units) Table 16. Global Bisphosphonate Drug Sales Market Share by Region (2016-2021) Table 17. Global Bisphosphonate Drug Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Bisphosphonate Drug Sales by Country (2016-2021) & (K Units) Table 19. North America Bisphosphonate Drug Sales Market Share by Country (2016-2021) Table 20. North America Bisphosphonate Drug Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Bisphosphonate Drug Revenue Market Share by Country (2016-2021) Table 22. Europe Bisphosphonate Drug Sales by Country (2016-2021) & (K Units) Table 23. Europe Bisphosphonate Drug Sales Market Share by Country (2016-2021) Table 24. Europe Bisphosphonate Drug Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Bisphosphonate Drug Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Bisphosphonate Drug Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Bisphosphonate Drug Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Bisphosphonate Drug Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Bisphosphonate Drug Revenue Market Share by Region (2016-2021) Table 30. Latin America Bisphosphonate Drug Sales by Country (2016-2021) & (K Units) Table 31. Latin America Bisphosphonate Drug Sales Market Share by Country (2016-2021) Table 32. Latin America Bisphosphonate Drug Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Bisphosphonate Drug Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Bisphosphonate Drug Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Bisphosphonate Drug Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Bisphosphonate Drug Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Bisphosphonate Drug Revenue Market Share by Country (2016-2021) Table 38. Global Bisphosphonate Drug Sales (K Units) by Type (2016-2021) Table 39. Global Bisphosphonate Drug Sales Market Share by Type (2016-2021) Table 40. Global Bisphosphonate Drug Revenue (Million US$) by Type (2016-2021) Table 41. Global Bisphosphonate Drug Revenue Share by Type (2016-2021) Table 42. Global Bisphosphonate Drug Price (USD/Unit) by Type (2016-2021) Table 43. Global Bisphosphonate Drug Sales (K Units) by Application (2016-2021) Table 44. Global Bisphosphonate Drug Sales Market Share by Application (2016-2021) Table 45. Global Bisphosphonate Drug Revenue (Million US$) by Application (2016-2021) Table 46. Global Bisphosphonate Drug Revenue Share by Application (2016-2021) Table 47. Global Bisphosphonate Drug Price (USD/Unit) by Application (2016-2021) Table 48. Merck Corporation Information Table 49. Merck Description and Business Overview Table 50. Merck Bisphosphonate Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Merck Bisphosphonate Drug Product Table 52. Merck Recent Developments/Updates Table 53. Teva Corporation Information Table 54. Teva Description and Business Overview Table 55. Teva Bisphosphonate Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Teva Bisphosphonate Drug Product Table 57. Teva Recent Developments/Updates Table 58. Mylan Corporation Information Table 59. Mylan Description and Business Overview Table 60. Mylan Bisphosphonate Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Mylan Bisphosphonate Drug Product Table 62. Mylan Recent Developments/Updates Table 63. Apotex Corp Corporation Information Table 64. Apotex Corp Description and Business Overview Table 65. Apotex Corp Bisphosphonate Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Apotex Corp Bisphosphonate Drug Product Table 67. Apotex Corp Recent Developments/Updates Table 68. Cobalt Pharmaceuticals Corporation Information Table 69. Cobalt Pharmaceuticals Description and Business Overview Table 70. Cobalt Pharmaceuticals Bisphosphonate Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Cobalt Pharmaceuticals Bisphosphonate Drug Product Table 72. Cobalt Pharmaceuticals Recent Developments/Updates Table 73. Genentech Corporation Information Table 74. Genentech Description and Business Overview Table 75. Genentech Bisphosphonate Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Genentech Bisphosphonate Drug Product Table 77. Genentech Recent Developments/Updates Table 78. Novartis Pharmaceuticals Corporation Information Table 79. Novartis Pharmaceuticals Description and Business Overview Table 80. Novartis Pharmaceuticals Bisphosphonate Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Novartis Pharmaceuticals Bisphosphonate Drug Product Table 82. Novartis Pharmaceuticals Recent Developments/Updates Table 83. Sanofi-Aventis Corporation Information Table 84. Sanofi-Aventis Description and Business Overview Table 85. Sanofi-Aventis Bisphosphonate Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Sanofi-Aventis Bisphosphonate Drug Product Table 87. Sanofi-Aventis Recent Developments/Updates Table 88. Production Base and Market Concentration Rate of Raw Material Table 89. Key Suppliers of Raw Materials Table 90. Bisphosphonate Drug Distributors List Table 91. Bisphosphonate Drug Customers List Table 92. Bisphosphonate Drug Market Trends Table 93. Bisphosphonate Drug Growth Drivers Table 94. Bisphosphonate Drug Market Challenges Table 95. Bisphosphonate Drug Market Restraints Table 96. Global Bisphosphonate Drug Sales Forecast by Type (2022-2027) & (K Units) Table 97. Global Bisphosphonate Drug Sales Market Share Forecast by Type (2022-2027) Table 98. Global Bisphosphonate Drug Revenue Forecast by Type (2022-2027) & (US$ Million) Table 99. Global Bisphosphonate Drug Revenue Market Share Forecast by Type (2022-2027) Table 100. Global Bisphosphonate Drug Sales Forecast by Application (2022-2027) & (K Units) Table 101. Global Bisphosphonate Drug Sales Market Share Forecast by Application (2022-2027) Table 102. Global Bisphosphonate Drug Revenue Forecast by Application (2022-2027) & (US$ Million) Table 103. Global Bisphosphonate Drug Revenue Market Share Forecast by Application (2022-2027) Table 104. Global Bisphosphonate Drug Sales Forecast by Region (2022-2027) & (K Units) Table 105. Global Bisphosphonate Drug Sales Market Share Forecast by Region (2022-2027) Table 106. Global Bisphosphonate Drug Revenue Forecast by Region (2022-2027) & (US$ Million) Table 107. Global Bisphosphonate Drug Revenue Market Share Forecast by Region (2022-2027) Table 108. Research Programs/Design for This Report Table 109. Key Data Information from Secondary Sources Table 110. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Bisphosphonate Drug Figure 2. Global Bisphosphonate Drug Market Share by Type in 2020 & 2027 Figure 3. Alendronate Product Picture Figure 4. Risedronate Product Picture Figure 5. Zoledronic Acid Product Picture Figure 6. Other Bisphosphonate Drug Product Picture Figure 7. Global Bisphosphonate Drug Market Share by Application in 2020 & 2027 Figure 8. Postmenopausal Osteoporosis Figure 9. Men with Osteoporosis Figure 10. Paget’s Disease Figure 11. Bone Loss Caused by Cancer Treatment Figure 12. Osteoporosis Imperfecta in Children Figure 13. Global Bisphosphonate Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Bisphosphonate Drug Market Size 2016-2027 (US$ Million) Figure 15. Global Bisphosphonate Drug Sales 2016-2027 (K Units) Figure 16. Global Bisphosphonate Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 17. Bisphosphonate Drug Sales Share by Manufacturers in 2020 Figure 18. Global Bisphosphonate Drug Revenue Share by Manufacturers in 2020 Figure 19. The Global 5 and 10 Largest Bisphosphonate Drug Players: Market Share by Revenue in 2020 Figure 20. Bisphosphonate Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 21. Global Bisphosphonate Drug Sales Market Share by Region (2016-2021) Figure 22. Global Bisphosphonate Drug Sales Market Share by Region in 2020 Figure 23. Global Bisphosphonate Drug Revenue Market Share by Region (2016-2021) Figure 24. Global Bisphosphonate Drug Revenue Market Share by Region in 2020 Figure 25. U.S. Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Canada Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Germany Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. France Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. U.K. Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Italy Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Russia Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. China Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Japan Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. South Korea Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. India Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Australia Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Taiwan Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Indonesia Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Thailand Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Malaysia Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Philippines Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Vietnam Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Mexico Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Brazil Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Argentina Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Turkey Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Saudi Arabia Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. U.A.E Bisphosphonate Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Sales Market Share of Bisphosphonate Drug by Type (2016-2021) Figure 50. Sales Market Share of Bisphosphonate Drug by Application (2016-2021) Figure 51. Sales Market Share of Bisphosphonate Drug by Application in 2020 Figure 52. Revenue Share of Bisphosphonate Drug by Application (2016-2021) Figure 53. Revenue Share of Bisphosphonate Drug by Application in 2020 Figure 54. Manufacturing Cost Structure of Bisphosphonate Drug Figure 55. Manufacturing Process Analysis of Bisphosphonate Drug Figure 56. Bisphosphonate Drug Industrial Chain Analysis Figure 57. Channels of Distribution Figure 58. Distributors Profiles Figure 59. Bottom-up and Top-down Approaches for This Report Figure 60. Data Triangulation Figure 61. Key Executives Interviewed

Merck Teva Mylan Apotex Corp Cobalt Pharmaceuticals Genentech Novartis Pharmaceuticals Sanofi-Aventis